Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Crism Thera Share News (CRTX)
CRTX Share
Price
CRTX Share
News3
CRTX Share
Chat3
CRTX Share
Trades8
CRTX
Live RNS1
CRTX Share
Charts
CRTX Level 2
Console
CRTX Live
Share Price
CRTX Broker
Ratings
CRTX Directors
Deals
CRTX Financial
Diary
CRTX
Fundamentals
CRTX Short
Positions
CRTX
Media
CRTX Company
Research2
CRTX Company
Timeline6
Share Price Information for Crism Thera (CRTX)
Last checked at -
Last checked at 
Intraday Crism Thera Share Chart
Crism Thera News
Crism reports positive preclinical results from prostate cancer model
(Sharecast News) - Crism Therapeutics reported positive preclinical results for its Docetaxel-ChemoSeed implant on Tuesday, highlighting improved effi...
WINNERS & LOSERS: Nichols trades in line; Crest Nicholson slumps
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
TRADING UPDATES: RWS launches AI offering; SulNOx patent wins
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
WINNERS & LOSERS: Volex beats consensus; Asos backs outlook
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.
AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.
TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
CRISM reports "significant" preclinical data for prostate cancer drug
(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substan...
EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...
Follow the stocks
